Drug intelligence / Profile preview

Shandong Univ. PELI1 compound 3d

Development stage
Unknown
Lead developer
Shandong University
01

Overview

Shandong Univ. PELI1 compound 3d: sourced facts only. name: "This novel PELI1 inhibitor 3d showed potent binding affinity to PELI1 (Kd 8.2 μM) in fluorescence quenching assay, and markedly interrupted the interaction of PELI1 and SNAIL/SLUG confirmed by co-immunoprecipitation." [PMID:38150964]; target: "This novel PELI1 inhibitor 3d showed potent binding affinity to PELI1 (Kd 8.2 μM) in fluorescence quenching assay, and markedly interrupted the interaction of PELI1 and SNAIL/SLUG confirmed by co-immunoprecipitation." [PMID:38150964]; developer: "Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, No. 44 West Wenhua Road, Jinan, Shandong, 250012, China; Weihai Marine Organism & Medical Technology Research Institute, Harbin Institute of Technology, Weihai, 264209, China." [PMID:38150964]; stage: "In the experimental lung metastasis model, 3d showed anti-TNBC metastasis efficacy without observable toxicity in vivo." [PMID:38150964]

02

Targets

PELI1 (Pellino E3 ubiquitin protein ligase 1)

Beyond the preview

Go deeper on Shandong Univ. PELI1 compound 3d.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shandong Univ. PELI1 compound 3d.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call